Global FKRP Registry
Global Fukutin-Related Protein Registry
Sponsor: CureLGMD2i
This observational or N/A phase trial investigates Congenital Muscular Dystrophy and FKRP Gene Mutation and is currently ongoing. CureLGMD2i leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Nov 2022 — Feb 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 5 earlier versions
-
Jan 2022 — Nov 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CureLGMD2i
- LGMD2i Research Fund
- Ludwig-Maximilians - University of Munich
- Newcastle University
For direct contact, visit the study record on ClinicalTrials.gov .